| pubmed-article:19884554 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C1335648 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C1333355 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:19884554 | lifeskim:mentions | umls-concept:C0444498 | lld:lifeskim |
| pubmed-article:19884554 | pubmed:issue | 34 | lld:pubmed |
| pubmed-article:19884554 | pubmed:dateCreated | 2009-11-26 | lld:pubmed |
| pubmed-article:19884554 | pubmed:abstractText | We evaluated the efficacy of gemcitabine versus gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer (NSCLC) and a performance status (PS) of 2 and assessed if tumoral RRM1 and ERCC1 protein levels are predictive of response to therapy. | lld:pubmed |
| pubmed-article:19884554 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19884554 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884554 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19884554 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19884554 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:LeeD BDB | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:SchellMichael... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:AsmarLinaL | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:BeplerGeroldG | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:ObasajuColema... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:CatonJohn RJR | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:BoulwareDavid... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:LiXueliX | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:BoehmKristi... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:ReynoldsCraig... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:MonbergMatthe... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:O'RourkeMark... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:PengGuangbinG | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:DemarcoLinda... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:Shaw... | lld:pubmed |
| pubmed-article:19884554 | pubmed:author | pubmed-author:BromundJaneJ | lld:pubmed |
| pubmed-article:19884554 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19884554 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19884554 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:19884554 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19884554 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19884554 | pubmed:pagination | 5808-15 | lld:pubmed |
| pubmed-article:19884554 | pubmed:dateRevised | 2011-3-3 | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:meshHeading | pubmed-meshheading:19884554... | lld:pubmed |
| pubmed-article:19884554 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19884554 | pubmed:articleTitle | Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer. | lld:pubmed |
| pubmed-article:19884554 | pubmed:affiliation | US Oncology, The Woodlands, TX, USA. | lld:pubmed |
| pubmed-article:19884554 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19884554 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19884554 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19884554 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| pubmed-article:19884554 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19884554 | lld:pubmed |
